BIOREGENX, INC.

BRGX
About the company

BioRegenx, Inc. engages in the research, development, and commercialization of dietary supplements, medical devices, software, and contactless diagnostic technologies in the United States and internationally. The company offers DocSun AI engine, which integrates with a ballistocardiograph that detects an individual's heartbeat; TruScan.AI mobile app for additional health indications; VitalWellness app for DNA and epigenetics platform; and Endocalyx Pro, a dietary supplement targeting microvascular capillary health.

Country: United StatesPrice: $0.00Market Cap: $97,157

Investment snapshot

6%positive consensus
Scored 1d ago

Positive

1

BUY / PASS

Neutral / negative

2 / 13

NEUTRAL / FAIL

Median fair value

—

No comparable estimates

Models with upside

0 / 17

Positive margin of safety

Strongest signal

7 of 10 pass — Buffett, Marks and Sleep object

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILNot rankedPASSFAILFAILFAILFAILFAILFAILFAILFAILNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Market data at 2026-11-01

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Market data at 2026-11-01

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-04-15

Score computed: 2026-11-14

Where It Passes

  • Cash Flow70% pass✓ 9✗ 3▾

    7 of 10 pass — Buffett, Marks and Sleep object

    Free Cash Flow Proxy$-1.5M
    ✗BuffettPositive and growing
    FCF Positive and Growing$0.0M
    ✓LynchPositive and growing
    Operating Cash Flow$0.0M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=9.48%, ROA=-375.58%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)2.5x
    ✓Dreman< 8x
    P/E or FCF YieldFCF Yield=30.8%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive1/3 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap30.9%
    ✓Ackman>= 4%
    Price / FCF per Share3.2x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency1/5 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$0.0M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+30.79%; #176/4519 (top 3.9%)
    ✓OshaughnessyTop 10% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✓ 5✗ 30▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)0/6 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)0/6 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-67.1% (latest)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-1.5M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)N/A (negative mean EPS)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROEN/A (negative equity)
    ✗Lynch> 15%
    EBIT / Enterprise Value-102.6%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-102.6%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-375.58%
    ✗PiotroskiROA > 0
    ROA Change YoY-4533.42% -> -375.58% (delta: +4157.84%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=9.48%, ROA=-375.58%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY70.9% -> 81.1%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity
    ✗Dreman> 12%
    Margin of Safety
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency0/5 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-67.1%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-99.9% (2023) -> -67.1% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 67.8% -> 81.1%, operating margin -99.9% -> -67.1%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-1588.74%; #6122/6340 (top 96.6%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+365.87%; #13/3702 (top 0.4%)
    ✓AsnessTop 30% of eligible cross-section
    Net income / positive book equity
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-17.1850; #5735/5884 (top 97.5%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years0/5 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Growth0% pass✗ 13▾

    All 8 investors flag BRGX's growth

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: -3.7% vs Rev: -20.8%
    ✗LynchInventory growth < Revenue growth
    EPS Growth Direction$0.00 (2021) -> $0.00 (2025)
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency0/5 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-20.8%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency1/4 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 67.8% -> 81.1%, operating margin -99.9% -> -67.1%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Efficiency0% pass✗ 11▾

    All 8 investors flag BRGX's efficiency

    Current Ratio0.06
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)-142.7%
    ✗Buffett> 10%
    ROIC - WACC-152.7%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)N/A (invested capital <= 0)
    ✗Greenblatt> 25%
    Current Ratio Change YoY0.08 -> 0.06
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY4.60x -> 4.51x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities0.06
    ✗Dreman> 1.5
    Return on Invested CapitalN/A (non-positive invested capital)
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/1 years above 12% (latest -112.7%)
    ✗SleepROIC > 12% in a majority of years
  • Verdicts7% pass✓ 1✗ 13▾

    Split decision: 13 FAIL · 2 NEUTRAL · 1 PASS

    Overall verdict
    ✗GrahamFAIL (0/9)✗BuffettFAIL (0/9)✗LynchFAIL (1/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 5)✗DremanFAIL (1/11)✗MungerFAIL (0/4)✗PabraiFAIL (1/3)✗AkreFAIL (1/6)✗MarksFAIL (0/5)✗AckmanFAIL (3/9)✗TempletonFAIL (3/8)✗SleepFAIL (1/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (0/7)•OshaughnessyNEUTRAL (Not ranked)
  • Debt & Leverage8% pass✓ 1✗ 14▾

    11 of 12 flag BRGX's debt & leverage — Graham, Buffett, Lynch +8 more

    LT Debt vs Net Current AssetsLT Debt $0.2M vs NCA $-3.8M
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: N/A (negative equity), IC: -4.2x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / EquityN/A (negative equity)
    ✗Lynch< 0.33
    Cash - Long-term Debt$-0.1M
    ✗LynchPositive preferred
    LT Debt / Total Assets Change50.07% -> 44.24%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities0.06
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt LevelsN/A (non-positive equity)
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=-4.2x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)
    ✗AsnessTop 30% of eligible cross-section
  • Valuation15% pass✓ 6✗ 22▾

    11 of 13 flag BRGX's valuation — Graham, Lynch, Greenblatt +8 more

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-102.6%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-102.6%, ROC=N/A (invested capital <= 0)
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)2.5x
    ✓Dreman< 8x
    Price / Book Value per ShareN/A (negative BVPS)
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-1524.8%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=30.8%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical Average
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share3.2x
    ✓Ackman<= 25
    Price vs. Trailing Low100% of trailing low ($0.00)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-1588.74%; #6122/6340 (top 96.6%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization-46.7002; #6357/6449 (top 98.6%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+19.0878; #218/5247 (top 4.2%)
    ✓OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+30.79%; #176/4519 (top 3.9%)
    ✓OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-99.16%; #6149/6202 (top 99.1%)
    ✗OshaughnessyTop 10% of eligible cross-section

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Business Services
Size: Micro Cap($97,157)
Revenue: $1.9M-20.8% YoY
Net Income: $1.5M+93.3% YoY

Financial Snapshot

Operating Margin-67.1%
Return on Equity34.0%
Debt / Equity-0.26
Current Ratio0.06
EPS (Diluted)$0.00
Shares Retired−1.3%

Similar Companies

ADPAUTOMATIC DATA PROCESSING INC
$122.3B
EAELECTRONIC ARTS INC.
$52.9B
RBRKRubrik, Inc.
$22.6B
ACMAECOM
$9.1B

Shareholder Return

Fiscal 2025

Issued 1.3% of shares last year.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-03-31

2025-04-01 – 2026-03-31

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex, revenue, net income, operating income, gross profit, ebit, interest expense.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-04-15
FY 2024
Sources
  • 10-K · 2025-04-15
FY 2023
Sources
  • 10-K · 2024-04-12
FY 2022
Sources
  • 10-K · 2023-04-04
FY 2021
Sources
  • 10-K · 2023-04-04
Market Cap$97.2Kcurrent--$11.6Mest.$11.8Mest.$10.2Mest.----
Revenue$1.8M↓23%$426.2K↓17%$1.9M↓21%$2.3M↓31%$3.4M↑7992%$42.2K↓79%$198.6K
Operating Income-$1.1M↑94%-$49.8K↑74%-$1.2M↑95%-$22.8M↓568%-$3.4M↓4253%-$78.3K↑53%-$165.1K
Net Income-$1.3M↑94%-$26.4K↑90%-$1.5M↑93%-$23.1M↓540%-$3.6M↓4497%-$78.3K↑19%-$96.9K
EPS (Diluted)--$0.00$0.00↑100%$-0.02$0.00$0.00$0.00
Gross Margin81.9%↑12%81.7%↑4%81.1%↑14%70.9%↑5%67.8%↓32%100.0%99.7%
Operating Margin-62.4%↑93%-11.7%↑69%-67.1%↑93%-972.7%↓873%-99.9%↑46%-185.7%↓123%-83.1%
ROE28.7%↓95%—34.0%↓95%682.2%↑293%173.8%↑5511%3.1%↓97%115.0%
Total Debt$1.1M$1.1M$1.2M↑4%$1.1M↑469%$200.0K$200.0K$200.0K
Shareholders' Equity-$4.5M↓27%-$4.5M↓27%-$4.5M↓34%-$3.4M↓63%-$2.1M↑18%-$2.5M↓2901%-$84.2K
Current Ratio0.05↓39%0.05↓39%0.06↓27%0.08↓64%0.23↑2147%0.01↓99%1.72
Debt / Equity-0.25↑22%-0.25↑22%-0.26↑22%-0.34↓249%-0.10↓22%-0.08↑97%-2.37
Operating Cash Flow$27.9K$26.6K↓29%$39.0K↑112%-$324.1K↑79%-$1.5M↓2243%-$64.7K↑46%-$119.5K
Free Cash Flow----$29.9K↑106%-$513.5K↑66%-$1.5M----

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Business Services

BRGX vs Peers — Financial Grading

Revenue$1.9MBottom 25%
Net Income$1.5MMedian
ROE34.0%Median
D/E-0.26Top 25%
Op. Margin-67.1%Bottom 25%
Curr. Ratio0.06Bottom 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
AUTOMATIC DATA PROCESSING INCADP$122.3B$309.93$21.9B$4.4B73.2%0.8224.2%1.054/95/93/70/3F-Score 65/11
ELECTRONIC ARTS INC.EA$52.9B$209.70$7.5B$887.0M13.1%0.2215.4%1.051/94/94/70/3F-Score 66/11
Rubrik, Inc.RBRK$22.6B$109.88$1.3B$348.8M67.1%—-26.2%1.691/90/92/70/3F-Score 62/11
AECOMACM$9.1B$70.50$16.1B$561.8M22.5%1.096.4%1.141/93/93/71/3F-Score 82/11
COMMVAULT SYSTEMS INCCVLT$6.2B$152.07$1.2B$70.7M942.8%—6.3%1.951/92/94/70/3F-Score 66/11
WPP plcWPP$6.0B$27.79$18.2B$289.5M-8.5%1.942.8%0.891/92/91/70/3F-Score 32/11
VARONIS SYSTEMS INCVRNS$5.6B$48.94$623.5M$129.3M-21.6%0.76-23.5%1.971/90/91/70/3F-Score 51/11
ROBERT HALF INC.RHI$4.3B$42.00$5.4B$133.0M10.4%—1.4%1.532/95/91/70/3F-Score 52/11